LC Sciences Breaking News Cepheid Tuberculosis Assay Receives WHO Prequalification VA Offering No-Cost PGx Testing Through End of 2025 GeneDx Launches Program to Boost Access to Exome Testing for Pediatric Epilepsy Patients LGC Acquires German Quality Controls Maker DiaMex Point-of-Care Testing Firm 52North Closes $6M Financing Round Lucid Diagnostics Raises $22M in Convertible Debt Refinancing